| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Journal of Virology, May 2008, p. 5021-5030, Vol. 82, No. 10
0022-538X/08/$08.00+0 doi:10.1128/JVI.00150-08
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Department of Microbiology and Immunology, New York State College of Veterinary Medicine, Cornell University, Ithaca, New York 14850
Received 21 January 2008/ Accepted 3 March 2008
The portal vertex of herpesvirus capsids serves as the conduit through which DNA is inserted during the assembly process. In herpes simplex virus (HSV), the portal is composed of 12 copies of the UL6 gene product, pUL6. Previous results identified a domain in the major capsid scaffold protein, ICP35, required for interaction with pUL6 and its incorporation into capsids formed in vitro (G. P. Singer et al., J. Virol. 74:6838-6848, 2005). In the current studies, pUL6 and scaffold proteins were found to coimmunoprecipitate from lysates of both HSV-infected cells and mammalian cells expressing scaffold proteins and pUL6. The coimmunoprecipitation of pUL6 and scaffold proteins was precluded upon deletion of codons 143 to 151 within UL26.5, encoding ICP35. While wild-type scaffold proteins colocalized with pUL6 when transiently coexpressed as viewed by indirect immunofluorescence, deletion of UL26.5 codons 143 to 151 precluded this colocalization. A recombinant herpes simplex virus, vJB11, was generated that lacked UL26.5 codons 143 to 151. A virus derived from this mutant but bearing a restored UL26.5 was also generated. vJB11 was unable to cleave or package viral DNA, whereas the restored virus packaged DNA normally. vJB11 produced ample numbers of B capsids in infected cells, but these lacked normal levels of pUL6. The deletion in UL26.5 also rendered pUL6 resistant to detergent extraction from vJB11-infected cells. These data indicate that, as was observed in vitro, amino acids 143 to 151 of ICP35 are critical for (i) interaction between scaffold proteins and pUL6 and (ii) incorporation of the HSV portal into capsids.
Published ahead of print on 12 March 2008.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|